Depression linked to neuro dysfunction, brain lesions in MSMay 13, 2020DepressionMultiple SclerosisMajor Depressive DisorderMental HealthNeurology
Database will collect data on COVID-19 in patients with MSApril 16, 2020COVID-19 UpdatesMultiple SclerosisNeurology
FDA removes pregnancy category C warning from certain MS medicationsApril 2, 2020Multiple SclerosisObstetricsGynecologyNeurologyWomen's Health
FDA approves ozanimod for relapsing and secondary progressive forms of MSMarch 26, 2020Multiple SclerosisNeurology
Clinicians petition government for national quarantineMarch 18, 2020COVID-19 UpdatesBusiness of MedicineMixed TopicsMultiple SclerosisInfectious DiseasesHealth Policy
Expert says progress in gut-brain research requires an open mindMarch 13, 2020GastroenterologySomatic DisordersParkinson's DiseaseAlzheimer's & CognitionMultiple SclerosisEpilepsy & SeizuresHeadache & Migraine
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MSMarch 12, 2020Multiple Sclerosis
Manual dexterity may decline more rapidly in pediatric-onset MSMarch 11, 2020Multiple SclerosisPediatricsNeurology
Age does not appear to affect efficacy of siponimod in secondary progressive MSMarch 10, 2020Multiple Sclerosis
Shared medical appointments educate and encourage MS patientsMarch 2, 2020Multiple SclerosisNeurology
Incomplete MS relapse recovery predicted greater long-term disabilityMarch 1, 2020Multiple SclerosisNeurology
Depression in MS predicted worsening of neurologic functionFebruary 29, 2020Multiple SclerosisDepressionNeurology
